Paige Lauttenbach, PA
Physician Assistant · Georgetown, SCNPI 1477111615
Payments from drug & device makers
Across 266 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$659
- Johnson & Johnson$581
- Novo Nordisk$577
- Amgen$294
- AstraZeneca$228
- UCB, Inc.$194
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,248100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $659 |
| Johnson & Johnson(2 entities) | 43 | $581 |
| Novo Nordisk | 33 | $577 |
| Amgen(2 entities) | 17 | $294 |
| AstraZeneca | 14 | $228 |
| UCB, Inc. | 11 | $194 |
| Dexcom, Inc. | 6 | $166 |
| Sanofi-aventis U.S. LLC | 11 | $153 |
| Antares Pharma, Inc. | 9 | $150 |
| Currax Pharmaceuticals LLC | 11 | $140 |
| Supernus Pharmaceuticals, Inc. | 3 | $137 |
| Mallinckrodt Hospital Products Inc. | 5 | $93 |
| Amarin Pharma, Inc. | 5 | $88 |
| Abbott | 5 | $84 |
| Pfizer | 5 | $84 |
| Lilly USA, LLC | 5 | $83 |
| Daiichi Sankyo Inc. | 4 | $71 |
| GSK | 3 | $65 |
| Astellas Pharma US Inc | 4 | $64 |
| Radius Health, Inc. | 4 | $49 |
| Boston Scientific | 2 | $36 |
| Exact Sciences | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $24 |
| Sonex Health, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Insulet Corporation | 1 | $13 |
| Bayer | 1 | $12 |
How this compares
$4,248 in reported general payments places this provider in the 85th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $31,316 |
| EliquisApixaban | 20 | $28,755 |
| MounjaroTirzepatide | 13 | $21,371 |
| LinzessLinaclotide | 13 | $12,877 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $12,211 |
| JanuviaSitagliptin Phosphate | 14 | $7,749 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $2,519 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,010 |
| Duloxetine Hcl | 43 | $1,543 |
| Escitalopram Oxalate | 62 | $1,205 |
| Levothyroxine Sodium | 110 | $1,203 |
| Fluticasone Propionate | 76 | $1,191 |
| Omeprazole | 81 | $1,029 |
| Bupropion XlBupropion Hcl | 29 | $974 |
| Losartan Potassium | 76 | $955 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $577 | $31,31618 claims |
| PfizerEliquis | $84 | $28,75520 claims |
| Lilly USA, LLCMounjaro | $83 | $21,37113 claims |
| AbbVieLinzess, Synthroid | $659 | $13,56328 claims |
| GSKTrelegy Ellipta | $65 | $12,21115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Georgetown
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
- Martha GreenSummerville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.